These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34271203)

  • 1. Reduction in COVID-19 prevalence in healthcare workers in a university hospital in southern Brazil after the start of vaccination.
    Toniasso SCC; Fernandes FS; Joveleviths D; Filho FFD; Takahasi AY; Baldin CP; Pereira RM; da Silva LP; Brum MCB
    Int J Infect Dis; 2021 Aug; 109():283-285. PubMed ID: 34271203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of two coronavirus disease 2019 (COVID-19) vaccines (viral vector and inactivated viral vaccine) against severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection in a cohort of healthcare workers.
    Marra AR; Miraglia JL; Malheiros DT; Guozhang Y; Teich VD; da Silva Victor E; Pinho JRR; Cypriano A; Vieira LW; Polonio M; Ornelas RH; de Oliveira SM; Borges Junior FA; Shibata ARO; Schettino GPP; de Oliveira KG; Ferraz Santana RA; de Mello Malta F; Amgarten D; Boechat AL; Trecenti NMZ; Kobayashi T; Salinas JL; Edmond MB; Rizzo LV
    Infect Control Hosp Epidemiol; 2023 Jan; 44(1):75-81. PubMed ID: 35351217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The Second Shot of CoronaVac Vaccine May Cause Reduction of Antibody Levels in People who Previously had COVID-19].
    Topkaya AE; Keskin AÜ; Dalan AB; Çıragil P
    Mikrobiyol Bul; 2022 Jan; 56(1):139-142. PubMed ID: 35088968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 infection after COVID-19 immunization in healthcare workers: A retrospective, pilot study.
    Vaishya R; Sibal A; Malani A; Prasad KH
    Indian J Med Res; 2021 May&Jun; 153(5&6):550-554. PubMed ID: 34341227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delay between COVID-19 complete vaccination and SARS-CoV-2 infection among healthcare workers.
    Saade A; Cha L; Tadié E; Jurado B; Le Bihan A; Baron-Latouche P; Febreau C; Thibault V; Garlantezec R; Tattevin P; Paris C
    Vaccine; 2022 May; 40(23):3159-3164. PubMed ID: 35465980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in healthcare workers: an observational study using surveillance data.
    Paris C; Perrin S; Hamonic S; Bourget B; Roué C; Brassard O; Tadié E; Gicquel V; Bénézit F; Thibault V; Garlantézec R; Tattevin P
    Clin Microbiol Infect; 2021 Nov; 27(11):1699.e5-1699.e8. PubMed ID: 34265462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Vaccine Breakthrough SARS-CoV-2 Infection and Associated Factors in Healthcare Workers of Trieste Teaching Hospitals (North-Eastern Italy).
    Basso P; Negro C; Cegolon L; Larese Filon F
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215930
    [No Abstract]   [Full Text] [Related]  

  • 8. High prevalence of SARS-CoV-2 infection among symptomatic healthcare workers in a large university tertiary hospital in São Paulo, Brazil.
    Buonafine CP; Paiatto BNM; Leal FB; de Matos SF; de Morais CO; Guerra GG; Martuchelli MVV; Oliveira DBL; Durigon EL; Soares CP; Candido ED; Telezynski BL; Sáfadi MAP; Almeida FJ
    BMC Infect Dis; 2020 Dec; 20(1):917. PubMed ID: 33267836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term immune response after inactivated SARS-CoV-2 (CoronaVac®, Sinovac) and ChAdOx1 nCoV-19 (Vaxzevria®, Oxford-AstraZeneca) vaccinations in health care workers.
    Jantarabenjakul W; Chantasrisawad N; Puthanakit T; Wacharapluesadee S; Hirankarn N; Ruenjaiman V; Paitoonpong L; Suwanpimolkul G; Torvorapanit P; Pradit R; Sophonphan J; Putcharoen O
    Asian Pac J Allergy Immunol; 2022 Sep; 40(3):269-277. PubMed ID: 34717527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of SARS-CoV-2 antibodies in vaccinated healthcare workers in Marrakech (Morocco).
    Ben Houmich T; Tali A; Debbagh F; Lamrani Hanchi A; Soraa N
    Int J Immunopathol Pharmacol; 2022; 36():3946320221133697. PubMed ID: 36215392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies Among Vietnamese Healthcare Workers by Dosing Interval for ChAdOx1 nCoV-19 Vaccine.
    Vu DM; Vu DTB; Do TTT; Olmsted AE; Dao BH; Thai TT; Nguyen CL; Le NTT; Le TA; Bui HTT; Pham TN; Moore MR
    Clin Infect Dis; 2022 Oct; 75(Suppl 2):S174-S181. PubMed ID: 35723271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 vaccine uptake in a multi-ethnic UK healthcare workforce: A cross-sectional study.
    Martin CA; Marshall C; Patel P; Goss C; Jenkins DR; Ellwood C; Barton L; Price A; Brunskill NJ; Khunti K; Pareek M
    PLoS Med; 2021 Nov; 18(11):e1003823. PubMed ID: 34739480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil.
    Katikireddi SV; Cerqueira-Silva T; Vasileiou E; Robertson C; Amele S; Pan J; Taylor B; Boaventura V; Werneck GL; Flores-Ortiz R; Agrawal U; Docherty AB; McCowan C; McMenamin J; Moore E; Ritchie LD; Rudan I; Shah SA; Shi T; Simpson CR; Barreto ML; Oliveira VA; Barral-Netto M; Sheikh A
    Lancet; 2022 Jan; 399(10319):25-35. PubMed ID: 34942103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knowledge, attitudes, and perceptions of COVID-19 vaccine and refusal to receive COVID-19 vaccine among healthcare workers in northeastern Ethiopia.
    Adane M; Ademas A; Kloos H
    BMC Public Health; 2022 Jan; 22(1):128. PubMed ID: 35042476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Factors Affecting Side Effects, Seroconversion Rates and Antibody Response After Inactivated SARS-CoV-2 Vaccination in Healthcare Workers].
    Şenol Akar Ş; Akçalı S; Özkaya Y; Gezginci FM; Cengiz Özyurt B; Deniz G; Karadağ Yalçın F; Özer D; Dündar Erbay P; Eser E
    Mikrobiyol Bul; 2021 Oct; 55(4):519-538. PubMed ID: 34666653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 antibody response after mRNA vaccination in healthcare workers with and without previous COVID-19, a follow-up study from a university hospital in Poland during 6 months 2021.
    Owsianka I; Pac A; Jachowicz E; Gutkowska K; Szczuciński W; Maziarz B; Sochacka-Tatara E; Heczko P; Sydor W; Żółtowska B; Wójkowska-Mach J
    Front Immunol; 2022; 13():1071204. PubMed ID: 36685606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of BNT162b2 mRNA Coronavirus Disease 2019 (COVID-19) Vaccine Against Acquisition of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Healthcare Workers in Long-Term Care Facilities: A Prospective Cohort Study.
    Muhsen K; Maimon N; Mizrahi A; Bodenheimer O; Cohen D; Maimon M; Grotto I; Dagan R
    Clin Infect Dis; 2022 Aug; 75(1):e755-e763. PubMed ID: 34698808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors Associated with Vaccine Breakthrough Incidence among Health Care Workers Vaccinated with Inactivated SARS-CoV2 Vaccine (CoronaVac).
    Anshory M; Wahono CS; Pratama MZ; Rahman PA; Nugraha AS; Sekarani A
    J Res Health Sci; 2022 Jun; 22(2):e00551. PubMed ID: 36511263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [COVID-19 infections and effectiveness of the vaccination among healthcare workers].
    Rojkovich B; Németh D; Dinya E; Nagy E; Török E; Lázár I; Perduk A; Géher P; Nagy G
    Orv Hetil; 2023 Feb; 164(5):163-171. PubMed ID: 36739547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of COVID-19 vaccine (Covaxin) against breakthrough SARS-CoV-2 infection in India.
    Behera P; Singh AK; Subba SH; Mc A; Sahu DP; Chandanshive PD; Pradhan SK; Parida SP; Mishra A; Patro BK; Batmanabane G
    Hum Vaccin Immunother; 2022 Dec; 18(1):2034456. PubMed ID: 35321625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.